Literature DB >> 6058495

Further observations on the mechanism of reticuloendothelial blockade.

D J Drutz, M G Koenig, D E Rogers.   

Abstract

The mechanism of the reticuloendothelial "blockade" which followed injection of large quantities of chromic phosphate without exogenous stabilizing material was investigated in Wistar rats. The RE blockade observed for several hours after induction appeared related to the continuing circulation of the chromic phosphate-blockading dose, and a reduction in the size of the particles used enhanced blockade. RE blockade appeared to be particles specific and was not related to a generalized depression of RE-phagocytic cell function. Studies in isolated perfused rat livers appeared to eliminate saturation of particle-specific macrophage clones as a likely explanation of blockade, and blockade could not be explained on the basis of depletion of serum opsonins. In the system employed, it is postulated that blockade occurs when large numbers of circulating particles saturate specific macrophage cell membrane-binding sites rather than from physical stuffing of RE-phagocytic cells.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6058495      PMCID: PMC2138415          DOI: 10.1084/jem.126.6.1087

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

1.  STUDIES OF THE RETICULOENDOTHELIAL SYSTEM (RES). 3. BLOCKADE OF THE RES IN MAN.

Authors:  H N WAGNER; M IIO
Journal:  J Clin Invest       Date:  1964-08       Impact factor: 14.808

2.  Lack of action of serum opsonins in phagocytosis of inert particles by cells of reticuloendothelial system.

Authors:  G BIOZZI; C STIFFEL; B N HALPERN; D MOUTON
Journal:  Proc Soc Exp Biol Med       Date:  1963-04

3.  The role of opsonins in the clearance of living and inert particles by cells of the reticuloendothelial system.

Authors:  C R JENKIN; D ROWLEY
Journal:  J Exp Med       Date:  1961-09-01       Impact factor: 14.307

4.  Latent period in the induction of reticuloendothelial blockade.

Authors:  H G PARKER; C R FINNEY
Journal:  Am J Physiol       Date:  1960-04

5.  Quantitative study of the granulopectic activity of the reticulo-endothelial system. II. A study of the kinetics of the R. E. S. in relation to the dose of carbon injected; relationship between the weight of the organs and their activity.

Authors:  G BIOZZI; B BENACERRAF; B N HALPERN
Journal:  Br J Exp Pathol       Date:  1953-08

6.  A METHOD OF DISTRIBUTING BETA-RADIATION TO THE RETICULO-ENDOTHELIAL SYSTEM AND ADJACENT TISSUES.

Authors:  H B Jones; C J Wrobel; W R Lyons
Journal:  J Clin Invest       Date:  1944-09       Impact factor: 14.808

7.  The effect of particle size on blood clearance and tissue distribution of radioactive gold colloids.

Authors:  D B ZILVERSMIT; G A BOYD; M BRUCER
Journal:  J Lab Clin Med       Date:  1952-08

8.  The effect of homologous and heterologous carrier on the clearance of colloidal material by the reticuloendothelial system.

Authors:  R L Schapiro; W J MacIntyre; D I Schapiro
Journal:  J Lab Clin Med       Date:  1966-08

9.  THE DYNAMICS OF RETICULOENDOTHELIAL BLOCKADE.

Authors:  M G KOENIG; R M HEYSSEL; M A MELLY; D E ROGERS
Journal:  J Exp Med       Date:  1965-07-01       Impact factor: 14.307

10.  The mechanism of blockade of the reticuloendothelial system.

Authors:  I M MURRAY
Journal:  J Exp Med       Date:  1963-01-01       Impact factor: 14.307

View more
  3 in total

1.  Affinity of antigen for white cells and its relation to the induction of antibody formation.

Authors:  D Sulitzeanu
Journal:  Bacteriol Rev       Date:  1968-12

2.  Effects of RES "blockade" on antibody formation. II. Cytokinetics of the secondary haemolysin response and suppressed immunological "memory" in mice treated with carbon particles.

Authors:  T Y Sabet; H Friedman
Journal:  Immunology       Date:  1969-10       Impact factor: 7.397

3.  Red cell survival studies in hereditary spherocytosis.

Authors:  J S Wiley
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.